
UK architecture firm RMJM has been appointed design architect for a state-of-the-art $US90 million biotechnology research and development centre in Beijing , it was announced recently. The new facility is for Genzyme Corp.
Click here for full Story http://www.medicalnewstoday.com/articles/106819.php |